Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1409142496;42497;42498 chr2:178634510;178634509;178634508chr2:179499237;179499236;179499235
N2AB1245037573;37574;37575 chr2:178634510;178634509;178634508chr2:179499237;179499236;179499235
N2A1152334792;34793;34794 chr2:178634510;178634509;178634508chr2:179499237;179499236;179499235
N2B502615301;15302;15303 chr2:178634510;178634509;178634508chr2:179499237;179499236;179499235
Novex-1515115676;15677;15678 chr2:178634510;178634509;178634508chr2:179499237;179499236;179499235
Novex-2521815877;15878;15879 chr2:178634510;178634509;178634508chr2:179499237;179499236;179499235
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATA
  • RefSeq wild type template codon: TAT
  • Domain: Ig-91
  • Domain position: 38
  • Structural Position: 56
  • Q(SASA): 0.5044
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/T None None 0.98 N 0.485 0.351 0.723184643479 gnomAD-4.0.0 1.5922E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85999E-06 0 0
I/V None None 0.4 N 0.208 0.093 0.51721326083 gnomAD-4.0.0 1.20033E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31251E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.5611 ambiguous 0.5048 ambiguous -0.743 Destabilizing 0.964 D 0.487 neutral None None None None N
I/C 0.8641 likely_pathogenic 0.833 pathogenic -0.65 Destabilizing 1.0 D 0.551 neutral None None None None N
I/D 0.8234 likely_pathogenic 0.7764 pathogenic -0.065 Destabilizing 0.991 D 0.533 neutral None None None None N
I/E 0.7187 likely_pathogenic 0.6712 pathogenic -0.143 Destabilizing 0.469 N 0.389 neutral None None None None N
I/F 0.2907 likely_benign 0.2681 benign -0.681 Destabilizing 0.998 D 0.439 neutral None None None None N
I/G 0.8536 likely_pathogenic 0.8128 pathogenic -0.932 Destabilizing 0.998 D 0.569 neutral None None None None N
I/H 0.7032 likely_pathogenic 0.6611 pathogenic -0.231 Destabilizing 1.0 D 0.629 neutral None None None None N
I/K 0.5664 likely_pathogenic 0.5262 ambiguous -0.371 Destabilizing 0.994 D 0.542 neutral N 0.465334137 None None N
I/L 0.1879 likely_benign 0.1802 benign -0.36 Destabilizing 0.911 D 0.327 neutral N 0.476116409 None None N
I/M 0.1547 likely_benign 0.1442 benign -0.394 Destabilizing 0.997 D 0.481 neutral N 0.501156472 None None N
I/N 0.435 ambiguous 0.3738 ambiguous -0.151 Destabilizing 0.998 D 0.617 neutral None None None None N
I/P 0.8178 likely_pathogenic 0.7962 pathogenic -0.454 Destabilizing 0.999 D 0.619 neutral None None None None N
I/Q 0.6513 likely_pathogenic 0.5992 pathogenic -0.357 Destabilizing 0.996 D 0.619 neutral None None None None N
I/R 0.4669 ambiguous 0.4296 ambiguous 0.156 Stabilizing 0.994 D 0.621 neutral N 0.498748545 None None N
I/S 0.5273 ambiguous 0.472 ambiguous -0.66 Destabilizing 0.996 D 0.508 neutral None None None None N
I/T 0.3641 ambiguous 0.3179 benign -0.623 Destabilizing 0.98 D 0.485 neutral N 0.505415311 None None N
I/V 0.1014 likely_benign 0.0952 benign -0.454 Destabilizing 0.4 N 0.208 neutral N 0.496745121 None None N
I/W 0.8815 likely_pathogenic 0.8645 pathogenic -0.692 Destabilizing 1.0 D 0.674 neutral None None None None N
I/Y 0.6638 likely_pathogenic 0.6285 pathogenic -0.445 Destabilizing 0.999 D 0.498 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.